This is because many patients would prefer not to use injectables
Receptor Pharmacology in Research Contexts Non-clinical characterization published by third parties describes uneven activity across the three targets, with reported potency at the GIP receptor exceeding that observed at the glucagon and GLP-1 receptors when measured against their endogenous ligands
Weight management research protocol The primary clinical application of retatrutide centers on weight management
Some are now also FDA-approved for chronic weight management
Many medications come with the risk of side effects, but the latest research has identified a possible link between GLP-1 medications and changes in smell and taste
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
